| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 04/18/2002 | WO2001072289A3 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001062709A3 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 04/18/2002 | WO2001060378A3 Antiadhesive carbohydrates |
| 04/18/2002 | WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045598 Nonacyclic nodulisporic acid derivatives |
| 04/18/2002 | US20020044952 Attenuated live neospora vaccine |
| 04/18/2002 | DE10047116A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/18/2002 | CA2423515A1 Pyrazole derivatives for the treatment of viral diseases |
| 04/18/2002 | CA2422718A1 Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
| 04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
| 04/17/2002 | EP1197215A2 Anthelmintic compositions |
| 04/17/2002 | EP1197207A2 Stable compositions for parenteral administration |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196439A2 Compounds exhibiting an antibiotic activity |
| 04/17/2002 | EP1196371A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 04/17/2002 | EP1196193A2 Interleukin-1 muteins useful as vaccine adjuvants |
| 04/17/2002 | EP1196159A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 04/17/2002 | EP0749305B1 Process for making avermectin/zein compositions |
| 04/17/2002 | CN1345327A 阿维菌素衍生物 Avermectin derivatives |
| 04/17/2002 | CN1345321A Optically pure camptothecin analogues |
| 04/17/2002 | CN1345313A Pesticidal enantiomer-pure 2,4-disubstituted oxazolines |
| 04/17/2002 | CN1082814C Nodulisporic acid derivatives |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372227 Oil in water emulsion containing a sterol and a saponin |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029035A2 Method to alter sugar moieties |
| 04/11/2002 | WO2002028408A2 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | WO2002028371A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | WO2002028370A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001049278A3 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 04/11/2002 | WO2000044334A3 Novel injectable muscle relaxant formulations |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020041886 Veterinary medicine |
| 04/11/2002 | US20020041882 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 04/11/2002 | DE10049468A1 New N-alkoxyalkyl-benzimidazole derivatives useful in veterinary medicine for the control of parasitic protozoa |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424567A1 Method to alter sugar moieties |
| 04/10/2002 | EP1195162A1 Vaccine preparations containing fatty acids as constituent |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194416A1 Halopyrimidines |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1087662B1 Composition for keeping away vermin |
| 04/10/2002 | EP1051159B1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343654A Process for preparing diclazuril as veterinary medicine for coccidiosis |
| 04/10/2002 | CN1082543C Polycyclic antiparasitic agents, process and strain for their prepn. and use |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369028 For combatting endoparasites |
| 04/09/2002 | US6368600 To protect animals from diseases caused by parasitic helminths, such heartworm disease |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026757A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026713A1 Antiparasitic compounds |
| 04/04/2002 | WO2002026226A1 Pharmaceutical composition of dihydroartemisinin for treating malaria |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids |
| 04/04/2002 | WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants |
| 04/04/2002 | WO2001066098A3 Therapeutic uses of ppar mediators |
| 04/04/2002 | WO2001039720A3 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 04/04/2002 | US20020040007 Novel macrolide antibiotics |
| 04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423487A1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/03/2002 | EP1193270A2 Pyrrolobenzodiazepines |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192142A1 Cyclo-imino depsipeptides and their utilization in controlling endoparasites |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191934A1 Il-8 receptor antagonists |
| 04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 04/03/2002 | EP1133319A4 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/03/2002 | CN1343209A Camptothecin derivatives having antitumor activity |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365165 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |